Status:
COMPLETED
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Noninfectious Posterior Uveitis
Eligibility:
All Genders
6+ years
Phase:
PHASE2
PHASE3
Brief Summary
This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-inf...
Eligibility Criteria
Inclusion
- Males or non-pregnant females at least 6 years of age who had been diagnosed and treated for recurrent, non-infectious uveitis affecting the posterior segment of one or both eyes for at least 1 year prior to the start of the study, and had 'quiet' eyes at surgery
Exclusion
- Coexisting medical or ocular conditions that would interfere with the study results
Key Trial Info
Start Date :
December 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT00407082
Start Date
December 1 2000
End Date
September 1 2005
Last Update
December 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Eye Center
Durham, North Carolina, United States, 27710